Obalon Therapeutics, Inc. (NASDAQ:OBLN) was founded in 2008 and is headquartered in Carlsbad, California, USA, with 113 full-time employees. It is a vertically integrated medical device company that focuses on the development and commercialization of medical devices to help reduce obesity by promoting weight loss. And provide treatment for overweight people.
Obalon Therapeutics, Inc. (OBLN):
Obalon Therapeutics, Inc. is a commercial-stage medical device company that focuses on the development and commercialization of medical devices that assist weight loss to treat obesity, overweight and overweight. The Obalon Balloon System provided by the company is designed to reduce weight for obese patients and sell products through distributors.
Obalon Balloon System is the first and only FDA-approved 3-balloon weight loss system that can be swallowed.
Obalon airbag system is a swallowable intragastric airbag system, suitable for temporary use to promote weight loss in obese (BMI 30-40 kg/m 2 ) adults who fail to achieve weight loss through diet and exercise. The system is intended to be used as an aid to moderate-intensity diet and behavior change programs. All balloons must be taken out within 6 months after placing the first balloon.